polycystic kidney disease, familiar benign haematuria, and renal graft rejection. Urinary excretion of 3-OHP was significantly higher in patients with Alport's syndrome compared with the patients with other renal diseases and the healthy control subjects. All Alport's syndrome, a hereditary disorder, is characterised by morphological and structural changes of the renal basement membranes. Morphologically, electron lucent and electron dense areas, cloudy networks, fraying, splitting, thickening, distortion, and thinning of the lamina densa may be observed by electron microscopy. ' However, the underlying mechanisms and molecular defects of the disease are still unclear.
Collagen type IV, an integral component of the glomerular basement membrane,2 is immunologically different in patients with Alport's syndrome compared with healthy subjects.?5 Hydroxyproline, a major constituent of collagens, was reported to be reduced in isolated glomerular basement membranes of patients with Alport's syndrome.6 Hydroxyproline exists in two stereoisomeric 'trans' forms: 4-trans-hydroxyproline (4-OHP) and 3-transhydroxyproline (3-OHP) but, unlike other connective tissue collagens, basement membranes normally contain large amounts of 3-OHP.7 As 3-OHP is excreted with the urine, changes in the collagen metabolism of the renal basement membranes could be reflected by a different urinary excretion of 3-OHP.
In order to test this hypothesis, and to find out characteristic differences, we studied the urinary excretion of 3-OHP in patients with Alport's syndrome, in healthy control subjects, and in patients with other renal diseases. The urinary concentration of 3-OHP was determined by thin layer chromatography. Urine samples were centrifuged at 3000 g for five minutes at room temperature and the supernatant used. The urinary volume used for chromatography was determined according to its creatinine content, which was analysed by Jaffe's method (Astra Beckman (R) Automatic Analyzer, Beckman). The volume containing 1 mg creatinine was added to 1 ml of 0-1 M phosphate buffer, pH 7 0, and 1 mg of charcoal (Sigma C 5385). This mixture was vortexed for 20 seconds and centrifuged at 2000 g for 10 minutes at room temperature. The pellet was resuspended in 1 ml of 0-1 M phosphate buffer, pH 7-0, centrifuged again at 2000 g for 10 minutes. The pooled supernatants were applied to columns containing 3 ml of Dowex 50 W X 8 (Bio Rad 745-6441), 100-200 mesh, in hydrogen form. Amino acids were eluted with 2 ml of. 4 M ammonia. The eluate was evaporated until dryness on a Pierce Reactitherm Heating Module and redissolved in 200 p1 distilled water. An aliquot of 100 iil of this solution was added to 20 ,ul o-phthalaldehyde (30% triethylamine, 70% ethanol, 8 mg/ml, Pierce 26-010). The mixture was incubated at room temperature in the dark for 30 minutes and then evaporated until dryness. The samples were redissolved in 20 tl 0-1 M phosphate buffer pH 7-0. Adding 20 ,ul 7-chloro-4-nitrobenz-2-oxa-1,3 diazole (8 mg dissolved in 1 ml ethanol), the samples were heated in a waterbath for 10 minutes at 40°C. The samples were spun for 5 minutes at 2000 g. Ten ,ul of the resulting supernatant were applied to HP thin layer chromatography plates (LHP-KF Whatman 4806). The development solution consisted of acetone:chloroform:methanol: triethylamine=20:60: 12-5:7-5). The plates were read at 365 nm on a Shimadzu TLC scanner CS 920; 4-trans-hydroxyproline (Sigma H 60 002), 4-cis-hydroxyproline (Sigma H 1 637), 3-transhydroxyproline, and 3-cis-hydroxyproline (synthesised by J Hausler8 ) were used as standards.
Specificity of the determinations on thin layer chromatography of 3-OHP was confirmed by high pressure liquid chromatography (HPLC) and by gas chromatography-mass spectrometry (GC-MS) in the standards used for the chromatography and in the urine samples obtained from the healthy adults. For the HPLC determinations checkpot samples, taken from the thin layer chromatography, were dissolved in elution buffer and characterised on reverse phase chromatography according to Lindblad and Diegelmann.9 For the GC-MS determinations N-trifluoroacetly-Otrimethylsilyl-hydroxyproline-trimethylsily-esters were prepared according to Donike, 10 (ii) analysis of the full mass spectra taken along with the GC separation of the derivatives at a rate of 1 sec/mass decade.
Differences between groups and within groups were analysed by the Kruskal-Wallis test.'2 Sensitivity of the 3-OHP determinations for detecting Alport's syndrome was defined as the proportion of patients with Alport's syndrome having a 3-OHP value above the range of the mean+2 SD of the 3-OHP values of the normal control subjects. Specificity of 3-OHP determinations for detecting Alport's syndrome was defined as the proportion of control subjects and of patients with other renal diseases having a 3-OHP value within the range of the mean and 2 SD of the normal control subjects.
Results
Polyacrylamide gel electrophoresis showed nonsignificant unspecific high molecular weight (= glomerular) proteinuria in 12/20 patients with Alport's syndrome.
Results of the thin layer chromatography determinations of 3-OHP are shown in the table and in fig 1 and 2 . They were highly significant differences between the 3-OHP values of the patients with Alport's syndrome compared with the normal control subjects and with the patients with other renal diseases but no difference between the latter and the normal control subjects.
In a single patient with Alport's syndrome the 3-OHP excretion was within the normal range (mean, 2 SD) of the healthy control subjects, and five control subjects had a 3-OHP value above the 2 sigma range of the healthy control subjects. All patients with other renal diseases had 3-OHP values within the normal range. Thus a specificity of 97-2% and a sensitivity of 95-2% of the thin layer chromatography 3-OHP determinations may be calculated for the patients with Alport's syndrome. ,uglmg creatinine by thin layer chromatography in patients with Alports syndrome (n=20), patients with other renal diseases (n=67), and normal control subjects (n=-109).
Results of the 3-OHP determinations
drome, in the normal controls, nor in the patients with other renal diseases (fig 3) . The identification of the 3-OHP bands by thin layer chromatography was confirmed by HPLC and GC-MS determination in all 12 urine samples investigated (fig 4) . nary excretion of glycosylated hydroxylysine, another amino acid which may be found in collagens of basement membranes in relatively low amounts. However, this was not confirmed by * * Schroder et al. 4 Figure 4 GC-MS spectrum of 3-hydroxyproline. collagen proteins. Cross linking and helical formation of collagens are possibly disturbed in Alport's syndrome.'7 Therefore non-helical collagens could be subjected to a prolonged action Among the normal control subjects there of post-translational enzymes, possibly preferwere significant differences between the 3-ably to 3-prolyl hydroxylase. This could lead to OHP values of the different age groups an increased excretion of 3-OHP whereas other (Kruskal-Wallis test, X2=62-98, p<0-0001), basement membrane amino acids such as 4-owing to a higher 3-OHP excretion in children, OHP and hydroxylysine would be excreted in toddlers, and infants (see table) . There were no normal amounts (see above). significant differences of the 3-OHP values
The high specificity and sensitivity of the among the patients with various renal diseases. increased 3-OHP excretion in patients with We found no correlation between age and 3-Alport's syndrome suggest that the determina-OHP values in the patients with Alport's syn-tion of 3-OHP could be helpful as a screening test for this disease, especially if the noninvasiveness, simplicity, and specificity of the method is taken into consideration. Further studies are needed to confirm its clinical relevance.
Corrosive injury to the oesophagus Early oesophagoscopy to assess the presence or extent of damage is now routine after caustic ingestion.' There has been doubt about the effectiveness of steroid drugs given to prevent oesophageal stenosis from the more severe injuries.
A trial done in Washington DC (Anderson et al, New England Joumal ofMedicine 1990;323:637-40) has shown no benefit from steroids given within 24 hours of the ingestion. A total of 131 children were assigned randomly to receive no treatment or steroids, initially given as intravenous prednisolone and later as oral prednisone for a total of five or six weeks. Ampicillin was given concurrendy with the steroid.
Oesophageal stricture developed in 10 of 31 children in the steroid group and in 11 of 29 untreated. Four steroid treated children and seven controls needed oesophageal replacement. Neither difference was statistically significant. 
